Compass Therapeutics, Inc.CMPXNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower.
Left:
||||
Year-over-year research & development expense growth
Latest
11.08%
Near historical average
Average (6y)
10.19%
Historical baseline
Range
High:47.50%
Low:-33.61%
Volatility
795.7%
High variability
| Period | Value |
|---|---|
| 2024 | 11.08% |
| 2023 | 27.08% |
| 2022 | 47.50% |
| 2021 | 36.45% |
| 2020 | -33.61% |
| 2019 | -17.15% |
| 2018 | 0.00% |